A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT02601885 · COMPLETED
Trial details
- NCT number
- NCT02601885
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-18
- Primary completion
- 2018-04-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.